UBS Group’s Response Genetics RGDX Stock Holding History
Bought
Maintained
Sold
UBS Group's RGDX Position: Q3 2015 in Review
UBS Group sold out of Response Genetics (RGDX) in Q3 2015, closing a stake of 16,621 shares — an estimated $5K sold.
UBS Group first reported a position in RGDX in Q1 2015 and held it in 2 quarters. The position peaked at $5K in Q2 2015. 1 fund tracked by Wall St. Rank holds RGDX as of Q3 2015.
- UBS Group reported no remaining Response Genetics position as of Q3 2015 after selling out during the quarter.
- UBS Group sold 16,621 Response Genetics shares in Q3 2015, an estimated $5K.
- UBS Group first reported a position in Response Genetics in Q1 2015 and held it in 2 quarters.
- UBS Group's Response Genetics position peaked at $5K in Q2 2015.
- 1 fund tracked by Wall St. Rank held Response Genetics as of Q3 2015.
Based on UBS Group's 13F filing for Q3 2015, filed 13 Nov 2015.